Symbol
RPTX on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Shares, no par value
Latest Disclosed Ownership
1.94M shares
Security Ownership
4.6%

ANSBERT GADICKE ownership in Repare Therapeutics Inc. Common Shares, no par value (RPTX)

2025-01-31 - ANSBERT GADICKE has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.94M shares of Repare Therapeutics Inc. Common Shares, no par value (RPTX). This represents 4.6% percent ownership of the company. In their previous filing dated 2025-01-15, MPM BioVentures 2014, L.P. had reported owning 2.15M shares, indicating a decrease of -9.69% percent.